Jazia prime vendor system- a public-private partnership to improve medicine availability in Tanzania: from pilot to scale.

Medicines management National roll-out Pharmaceutical procurement Pilot to scale Prime vendor Public-private partnership Supply chain Tanzania

Journal

Journal of pharmaceutical policy and practice
ISSN: 2052-3211
Titre abrégé: J Pharm Policy Pract
Pays: England
ID NLM: 101627192

Informations de publication

Date de publication:
2019
Historique:
received: 17 08 2018
accepted: 10 01 2019
entrez: 21 3 2019
pubmed: 21 3 2019
medline: 21 3 2019
Statut: epublish

Résumé

The availability of medicines in public health facilities in Tanzania is problematic. Medicines shortages are often caused by unavailability at Medical Stores Department, the national supplier for public health facilities. During such stock-outs, districts may purchase from private suppliers. However, this procedure is intransparent, bureaucratic and uneconomic. To complement the national supply chain in case of stock-outs with a simplified, transparent and efficient procurement procedure based on a public-private partnership approach with a prime vendor at the regional level. To develop a successful pilot of a Prime Vendor system with the potential for national scale-up. A public-private partnership was established engaging one private sector pharmaceutical supplier as the Prime Vendor to provide the complementary medicines needed by public health facilities in Tanzania. The Dodoma pilot region endorsed the concept involving the private sector, and procedures to procure complementary supplies from a single vendor in a pooled regional contract were developed. A supplier was tendered and contracted based on Good Procurement Practice. Pilot implementation was guided by Standard Operating Procedures, and closely monitored with performance indicators. A 12-step approach for national implementation was applied including cascade training from national to facility level. Each selected vendor signed a contract with the respective regional authority. In the pilot region, tracer medicines availability increased from 69% in 2014 to 94% in 2018. Prime vendor supplies are of assured quality and average prices are comparable to prices of Medical Stores Department. Procurement procedures are simplified, shortened, standardized, transparent and well-governed. Procurement capacity was enhanced at all levels of the health system. Proven successful, the Prime Vendor system pilot was rolled-out nationally, on government request, to all 26 regions of mainland Tanzania, covering 185 councils and 5381 health facilities. The Prime Vendor system complements regular government supply through a regional contract approach. It is anchored in the structures of the regional health administration and in the decentralisation policy of the country. This partnership with the private sector facilitates procurement of additional supplies within a culture of transparency and accountability. Regional leadership, convincing pilot results and policy dialogue have led to national roll-out. Transferring this smaller-scale supply chain intervention to other regions requires country ownership and support for sustainable operations.

Sections du résumé

BACKGROUND BACKGROUND
The availability of medicines in public health facilities in Tanzania is problematic. Medicines shortages are often caused by unavailability at Medical Stores Department, the national supplier for public health facilities. During such stock-outs, districts may purchase from private suppliers. However, this procedure is intransparent, bureaucratic and uneconomic.
OBJECTIVES OBJECTIVE
To complement the national supply chain in case of stock-outs with a simplified, transparent and efficient procurement procedure based on a public-private partnership approach with a prime vendor at the regional level. To develop a successful pilot of a Prime Vendor system with the potential for national scale-up.
METHODS METHODS
A public-private partnership was established engaging one private sector pharmaceutical supplier as the Prime Vendor to provide the complementary medicines needed by public health facilities in Tanzania. The Dodoma pilot region endorsed the concept involving the private sector, and procedures to procure complementary supplies from a single vendor in a pooled regional contract were developed. A supplier was tendered and contracted based on Good Procurement Practice. Pilot implementation was guided by Standard Operating Procedures, and closely monitored with performance indicators. A 12-step approach for national implementation was applied including cascade training from national to facility level. Each selected vendor signed a contract with the respective regional authority.
RESULTS RESULTS
In the pilot region, tracer medicines availability increased from 69% in 2014 to 94% in 2018. Prime vendor supplies are of assured quality and average prices are comparable to prices of Medical Stores Department. Procurement procedures are simplified, shortened, standardized, transparent and well-governed. Procurement capacity was enhanced at all levels of the health system. Proven successful, the Prime Vendor system pilot was rolled-out nationally, on government request, to all 26 regions of mainland Tanzania, covering 185 councils and 5381 health facilities.
CONCLUSION CONCLUSIONS
The Prime Vendor system complements regular government supply through a regional contract approach. It is anchored in the structures of the regional health administration and in the decentralisation policy of the country. This partnership with the private sector facilitates procurement of additional supplies within a culture of transparency and accountability. Regional leadership, convincing pilot results and policy dialogue have led to national roll-out. Transferring this smaller-scale supply chain intervention to other regions requires country ownership and support for sustainable operations.

Identifiants

pubmed: 30891247
doi: 10.1186/s40545-019-0163-4
pii: 163
pmc: PMC6388475
doi:

Types de publication

Journal Article

Langues

eng

Pagination

4

Déclaration de conflit d'intérêts

Not applicable.Not applicable.The authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Références

Int J Equity Health. 2014 Dec 20;13:123
pubmed: 25532714
J Pharm Policy Pract. 2015 Feb 16;8(1):8
pubmed: 25825675
Soc Sci Med. 2015 May;133:21-7
pubmed: 25829195
Implement Sci. 2015 Aug 12;10:113
pubmed: 26264351
Health Econ Rev. 2015 Dec;5(1):62
pubmed: 26329425
Glob Health Action. 2015 Dec 15;8:29648
pubmed: 26679408
BMC Pharmacol Toxicol. 2015 Dec 23;16:43
pubmed: 26699711
Glob Public Health. 2016;11(4):407-22
pubmed: 26883021
BMC Health Serv Res. 2016 Sep 21;16(1):504
pubmed: 27655007
PLoS One. 2016 Oct 18;11(10):e0164366
pubmed: 27755558
BMC Health Serv Res. 2016 Oct 21;16(1):596
pubmed: 27769234
PLoS One. 2016 Nov 3;11(11):e0165707
pubmed: 27812177

Auteurs

Karin Wiedenmayer (K)

1Swiss Tropical and Public Health Institute, Basel, Switzerland.
2University of Basel, Petersplatz 1, 4051 Basel, Switzerland.

Romuald Mbwasi (R)

3Senior pharmaceutical consultant, Dar es Salaam and senior lecturer at St. John's University of Tanzania, Dodoma, Tanzania.

William Mfuko (W)

Senior pharmaceutical consultant, Dar es Salaam, Dodoma, Tanzania.

Ezekiel Mpuya (E)

Health System Resource Center, President's Office Regional Administration and Local Government, Dodoma, Tanzania.

James Charles (J)

Regional Medical Officer, Regional Administrative Secretary's Office, Dodoma, Tanzania.

Fiona Chilunda (F)

Health Promotion and System Strengthening Project, Dodoma, Tanzania.

Denis Mbepera (D)

Regional Pharmacist, Regional Administrative Secretary's Office, Dodoma, Tanzania.

Ntuli Kapologwe (N)

Director of Health Services, Social Welfare and Nutrition Services, President's Office of Regional Administration and Local Government, Dodoma, Tanzania.

Classifications MeSH